Niagen® (patented nicotinamide riboside) may reduce production of inflammatory cytokines in pilot study of Stage D heart failure patients LOS ANGELES–(BUSINESS WIRE)–ChromaDex Corp. (NASDAQ:CDXC) today announced the 11th published human trial on its patented NAD-boosting nutrient Niagen®, further highlighting its potential to support cardiovascular health in humans. A NIH funded study […]
Coronary/Structural Heart
Foldax Named a Finalist in the Fierce Innovation Awards – Life Sciences Edition 2020
Tria Heart Valve Made with Proprietary LifePolymer Reimagines Material, Design and Manufacturing to Solve Long-Standing Heart Valve Issues SALT LAKE CITY–(BUSINESS WIRE)–Foldax® announced today that it has been selected as a finalist in the Fierce Innovation Awards – Life Sciences Edition 2020, a peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma, […]
Philips introduces OmniWire, the world’s first solid core pressure guide wire for coronary artery interventional procedures
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of OmniWire, the world’s first solid core pressure wire for coronary artery interventional procedures. With its breakthrough solid core construction, physicians can more easily maneuver the wire in the patient’s circulatory system to […]
Neovasc Provides Corporate Update
VANCOUVER and MINNEAPOLIS, MN, Aug. 13, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), today provided a corporate update on progress towards its value creation strategies. Fred Colen, Chief Executive Officer of Neovasc, commented, “We are pleased to provide a corporate update to our investors as we have […]
CE Marking Received for Core European Product, DyeVert Power XT
Key Highlights Osprey Medical has received European CE Marking approval for the 2nd generation DyeVert Power XT device Approval of DyeVert Power XT (for automatic injection) means the full coronary angiography market is now available to Osprey’s DyeVert franchise Device is expected to be a core product in the product portfolio […]
LivaNova to Present Autonomic Regulation Therapy Findings for Heart Failure During European Society of Cardiology Congress 2020
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) a market-leading medical technology and innovation company, today announced it will present a poster at the European Society of Cardiology (ESC) Congress 2020 on the potential for autonomic regulation therapy (ART) via vagus nerve stimulation to improve long-term cardiovascular function in patients with heart failure. The virtual Congress […]
FDA Accepts Evinacumab Biologics License Application for Priority Review as a Treatment for Patients with HoFH, an Ultra-rare Inherited Form of High Cholesterol
TARRYTOWN, N.Y., Aug. 12, 2020 /PRNewswire/ — Homozygous familial hypercholesterolemia affects approximately 1,300 patients in the U.S., the vast majority of whom are unable to reach target LDL-C levels with currently available therapies Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review a […]
Myocardial Solutions Announces Strategic Partnership with United Imaging, Bringing Rapid Cardiac MR Imaging to Unmet Cancer Care and Cardiology Markets
MORRISVILLE, N.C., Aug. 11, 2020 /PRNewswire/ — Myocardial Solutions, Inc. (“MSI”) and United Imaging, Inc. (“United Imaging”) have formed a strategic partnership to open new cancer care and cardiology markets for rapid cardiac magnetic resonance (MR) imaging. The partnership will focus on providing cancer centers and hospitals with critical MyoStrain®-enabled solutions for the […]
MyoKardia and LianBio Form Strategic Partnership to Develop and Commercialize Mavacamten Together in Greater China
Near-Term Focus on Pursuing Approval of Mavacamten for Obstructive HCM Innovative Model Focused on Long-Term Value Creation: MyoKardia Receives Equity Position in Lian Cardiovascular and Tassos Gianakakos, MyoKardia’s CEO, to Join LianBio Board of Directors BRISBANE, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK) and LianBio announced […]
Confluent Medical Opens New Catheter Development Center
Austin, TX center supports initial design through pilot builds AUSTIN, Texas–(BUSINESS WIRE)–Confluent Medical Technologies (“Confluent”), a global leader in contract manufacturing of specialized medical devices, today announced the opening of its new Complex Catheter Design and Development Center in Austin, Texas. The state-of-the-art, rapid-prototyping, development and pilot facility greatly expands […]
Recent
RadNet Secures $250 Million Incremental Term Loan to Fund Strategic Growth Opportunities and Reduces the Interest Rates on its Credit Facility by 0.25%
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
ThruFlo Endovascular Secures Seed Funding to Advance First Purpose-Built Flow Diverter for Bifurcation Aneurysms
Popular
- No commented posts yet